Scenarios that move BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
Scenarios that move BCRX: 1 analysis, 0 positive, 1 negative.
- · Rubico announces $8.5 million registered direct convertible note and warrant offering — ▼ · impact -50 · confidence low · horizon immediate